Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALKVariant Type and ALKWith or Without TP53Mutations
- Resource Type
- Article
- Source
- Journal of Thoracic Oncology; November 2023, Vol. 18 Issue: 11 p1581-1593, 13p
- Subject
- Language
- ISSN
- 15560864; 15561380